THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY : Impact Factor & More
eISSN: 2045-1261pISSN: 2045-1253
Open AccessShare this on:
Key Metrics
Impact Factor 
< 5
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ 
SJR
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 10 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | British Association for Psychopharmacology |
| Frequency | Continuous publication |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
Benzodiazepine receptor agonist deprescribing principles for long-term use and dependence: modified Delphi recommendations from a multi-disciplinary expert panel
- 9 Jun 2026
- Therapeutic Advances in Psychopharmacology
Cariprazine augmentation for negative symptoms of schizophrenia: a prospective analysis and literature review
- 4 Jun 2026
- Therapeutic Advances in Psychopharmacology
Adjunctive aripiprazole for amisulpride-induced hyperprolactinemia: a preliminary retrospective study showing no reversing effect
- 27 May 2026
- Therapeutic Advances in Psychopharmacology
Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression
- 22 May 2026
- Therapeutic Advances in Psychopharmacology
Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians
- 20 May 2026
- Therapeutic Advances in Psychopharmacology
Corrigendum to \u201cIntranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study\u201d
- 19 May 2026
- Therapeutic Advances in Psychopharmacology
Benzodiazepine receptor agonist deprescribing principles for long-term use and dependence: modified Delphi recommendations from a multi-disciplinary expert panel
- 9 Jun 2026
- Therapeutic Advances in Psychopharmacology
Cariprazine augmentation for negative symptoms of schizophrenia: a prospective analysis and literature review
- 4 Jun 2026
- Therapeutic Advances in Psychopharmacology
Adjunctive aripiprazole for amisulpride-induced hyperprolactinemia: a preliminary retrospective study showing no reversing effect
- 27 May 2026
- Therapeutic Advances in Psychopharmacology
Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression
- 22 May 2026
- Therapeutic Advances in Psychopharmacology
Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians
- 20 May 2026
- Therapeutic Advances in Psychopharmacology
Corrigendum to \u201cIntranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study\u201d
- 19 May 2026
- Therapeutic Advances in Psychopharmacology
FAQs on THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
How long has THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY been actively publishing? 
What is the publishing frequency of THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY?
How many articles did THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY publish last year?
What is the eISSN & pISSN for THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY?
Who is the publisher of THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY?
